Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
afimoxifene
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Besins Healthcare
Drug class:
Selective estrogen receptor modulator
Related drugs:
‹
toremifene (4)
lasofoxifene (3)
Z-endoxifen hydrochloride (2)
Z-endoxifen (1)
acolbifene (0)
LY353381 (0)
ormeloxifene (0)
raloxifene hydrochloride (0)
toremifene (4)
lasofoxifene (3)
Z-endoxifen hydrochloride (2)
Z-endoxifen (1)
acolbifene (0)
LY353381 (0)
ormeloxifene (0)
raloxifene hydrochloride (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
FGFR1 amplification
Breast Cancer
FGFR1 amplification
Breast Cancer
afimoxifene
Resistant: D – Preclinical
afimoxifene
Resistant
:
D
afimoxifene
Resistant: D – Preclinical
afimoxifene
Resistant
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login